Please assess the completion status of the following clinical trial:

Trial Title: Efficacy and Safety of Calcipotriol Plus Betamethasone Dipropionate Gel in Scalp Psoriasis

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: DOUBLE
- Phase: PHASE3
- Number of Arms: None

Eligibility Criteria:
Inclusion Criteria:~* Scalp psoriasis amenable to topical treatment with a maximum of 100 g of medication per week~* Clinical signs of psoriasis vulgaris on trunk and/or limbs, or earlier diagnosed with psoriasis vulgaris on trunk and/or limbs~* Extent of scalp psoriasis involving more than 10% of the total scalp area~* Investigator's assessment of clinical signs of the scalp of at least 2 in one of the clinical signs, erythema, thickness and scaliness, and at least 1 in each of the other two clinical signs~* Disease severity on the scalp graded as Mild, Moderate, Severe or Very severe according to the investigator's global assessment of disease severity~Exclusion Criteria:~* PUVA or Grenz ray therapy within 4 weeks prior to randomisation~* UVB therapy within 2 weeks prior to randomisation~* Systemic treatment with biological therapies, with a possible effect on scalp psoriasis within 6 months prior to randomisation~* Systemic treatment with all other therapies than biologicals, with a possible effect on scalp psoriasis (e.g., corticosteroids, vitamin D analogues, retinoids, immunosuppressants) within 4 weeks prior to randomisation~* Any topical treatment of the scalp (except for medicated shampoos and emollients) within 2 weeks prior to randomisation~* Topical treatment of the face, trunk and/or limbs with very potent WHO group IV corticosteroids within 2 weeks prior to randomisation~* Current diagnosis of erythrodermic, exfoliative or pustular psoriasis

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: f

Based on this trial design, predict the completion outcome and termination type (if applicable).